Skip to main content
logo
Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
93.27
+1.38 (1.50%)
At close: Jan 21, 2026, 4:00 PM EST
93.20
-0.07 (-0.08%)
Pre-market: Jan 22, 2026, 5:47 AM EST

Mirum Pharmaceuticals Revenue

Mirum Pharmaceuticals had revenue of $133.01M in the quarter ending September 30, 2025, with 47.17% growth. This brings the company's revenue in the last twelve months to $471.79M, up 53.66% year-over-year. In the year 2024, Mirum Pharmaceuticals had annual revenue of $336.89M with 80.76% growth.

Revenue (ttm)
$471.79M
Revenue Growth
+53.66%
P/S Ratio
9.76
Revenue / Employee
$1,465,199
Employees
322
Market Cap
4.82B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024336.89M150.51M80.76%
Dec 31, 2023186.37M109.31M141.85%
Dec 31, 202277.06M57.92M302.66%
Dec 31, 202119.14M--
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.64.24B
AbbVie59.64B
Eli Lilly and Company59.42B
AstraZeneca58.13B
Novartis AG56.37B
Novo Nordisk49.58B
Revenue Rankings

MIRM News

More News